s6y
Company name or ticker
Search
Allen Andrew R
4
Adaptimmune Therapeutics PLC: Statement of changes in beneficial ownership of securities
Filed
Wednesday, July 5, 2023
Period
Jul 5, 2023
Accession number
0001104659-23-078197
Documents
OWNERSHIP DOCUMENT
4
On sec.gov
Filing index
All files
Complete submission text
SGML header